Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis.
about
Therapeutic Drug Monitoring of Posaconazole: an UpdateTrypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental ModelPractice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazoleLung transplantation for cystic fibrosis: results, indications, complications, and controversies.Pharmacokinetics of Posaconazole Suspension in Lung Transplant Patients with and without Cystic Fibrosis.Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus Strains.Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.Posaconazole salvage treatment for invasive fungal infection.Review of the new delayed-release oral tablet and intravenous dosage forms of posaconazole.Antifungal agents and liver toxicity: a complex interaction.Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus infections.Utilization of posaconazole oral suspension or delayed-released tablet salvage treatment for invasive fungal infection.Efficacy and safety of posaconazole in hematopoietic stem cell transplantation patients with invasive fungal disease.Hepatotoxicity of Antimycotics Used for Invasive Fungal Infections: In Vitro Results.Posaconazole in lung transplant recipients: use, tolerability, and efficacy.Switching to anidulafungin from caspofungin in cancer patients in the setting of liver dysfunction is associated with improvement of liver function tests.Posaconazole: An Update of Its Clinical Use.Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections.Posaconazole liquid vs tablet formulation in lung transplant recipients.Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis.Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis.
P2860
Q26746016-F76624C7-176D-434B-8D30-D4511A7D68C0Q28553573-32F9F9C8-94B2-461E-9DD0-6CD3738AB942Q34532546-511850C1-8ED9-4633-8778-C337F0BA99EFQ35732778-8A533B51-FACD-4E3C-AD00-ABFDC342D451Q36658777-DEF54D1B-395C-4290-95E9-124987000F68Q36933524-7A56925D-A7AD-4AD0-8C02-8BA0BA54DD22Q37358747-14B780A2-0DCA-4587-8E6C-4076DB8A2558Q38140015-75C718E8-3D58-43E4-85FA-3C2C2090F01CQ38237895-DB6833B1-8B02-43E2-8573-222B0B2FEFA9Q38341595-6B617A24-EAFA-496C-94B6-76B2259DE9C8Q38858839-3137775F-0FED-4CEB-94A9-27C3444DB794Q38871233-D106720A-9564-48FE-B24C-B42F3304FD08Q38890514-7B160853-0D63-4D4D-9CB4-869A87879E7EQ40062960-CF47FBA1-4DC3-4EF2-AEC0-4D9EA20CB0DFQ40225550-E8C3D83A-1356-4FDF-A44F-0239DF622F13Q40827808-AF925544-09EB-45F8-AE58-30B99D49AF43Q41031277-123068F1-B2CA-4505-9A7C-AFAD60697EA8Q42144246-52899FA9-8EE1-4FA8-8BF5-24A041F15493Q47141618-9B93697A-2F88-4027-B04E-F8B44EB5EBECQ48354018-B48AB2C2-5496-4B46-94F3-7F1E19B3A201Q54243380-A0AFB28A-7F37-412E-BAE7-8D95AAD2E1D2Q54253897-0EB4FAD3-E0A8-4428-B17E-D3D9951EC98D
P2860
Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Posaconazole after previous an ...... ase, a retrospective analysis.
@en
Posaconazole after previous an ...... ase, a retrospective analysis.
@nl
type
label
Posaconazole after previous an ...... ase, a retrospective analysis.
@en
Posaconazole after previous an ...... ase, a retrospective analysis.
@nl
prefLabel
Posaconazole after previous an ...... ase, a retrospective analysis.
@en
Posaconazole after previous an ...... ase, a retrospective analysis.
@nl
P2093
P2860
P356
P1433
P1476
Posaconazole after previous an ...... ease, a retrospective analysis
@en
P2093
Angelika Boehme
Gerlinde Egerer
Heinrich Lellek
Jochen Greiner
P2860
P304
P356
10.1111/MYC.12023
P577
2012-11-21T00:00:00Z